Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 116

1.

Postpartum use of oxytocin and volume of placental transfusion: a randomised controlled trial.

Vain NE, Satragno DS, Gordillo JE, Fernandez AL, Carrolli G, Romero NP, Prudent LM.

Arch Dis Child Fetal Neonatal Ed. 2019 May 9. pii: fetalneonatal-2018-316649. doi: 10.1136/archdischild-2018-316649. [Epub ahead of print]

PMID:
31072967
2.

Protein structural defects enable pharmaceutical targeting while functionalizing the M2 proton channel.

Fernández A.

Biochem Biophys Res Commun. 2019 Jun 18;514(1):86-91. doi: 10.1016/j.bbrc.2019.04.094. Epub 2019 Apr 23.

PMID:
31023526
3.

Using a variant of coverslip hypoxia to visualize tumor cell alterations at increasing distances from an oxygen source.

Arocena M, Landeira M, Di Paolo A, Silva A, Sotelo-Silveira J, Fernández A, Alonso J.

J Cell Physiol. 2019 Mar 25. doi: 10.1002/jcp.28507. [Epub ahead of print]

PMID:
30912143
4.

Reverse Engineering of a Thermosensing Regulator Switch.

Inda ME, Vazquez DB, Fernández A, Cybulski LE.

J Mol Biol. 2019 Mar 1;431(5):1016-1024. doi: 10.1016/j.jmb.2019.01.025. Epub 2019 Jan 25.

PMID:
30738600
5.

Drug-based cancer therapy to overcome immune resistance by steering tumor evolution.

Fernández A.

Expert Opin Drug Discov. 2019 Jan;14(1):5-8. doi: 10.1080/17460441.2019.1550066. Epub 2018 Nov 29. No abstract available.

PMID:
30486683
6.

Performance of the Pediatric Index of Mortality 3 Score in PICUs in Argentina: A Prospective, National Multicenter Study.

Arias López MDP, Boada N, Fernández A, Fernández AL, Ratto ME, Siaba Serrate A, Schnitzler E; Members of VALIDARPIM3 Argentine Group.

Pediatr Crit Care Med. 2018 Dec;19(12):e653-e661. doi: 10.1097/PCC.0000000000001741.

7.

Targeted therapy to annihilate the immune-evading phenotype in cancer evolution.

Fernández A.

Expert Opin Ther Targets. 2018 Jul;22(7):559-562. doi: 10.1080/14728222.2018.1450867. Epub 2018 Mar 13. No abstract available.

PMID:
29517390
8.

Engineering Tumor Hypersusceptibility to Checkpoint Immunotherapy.

Fernández A.

Trends Cancer. 2017 Oct;3(10):675-677. doi: 10.1016/j.trecan.2017.08.002. Epub 2017 Sep 4. Review.

PMID:
28958385
9.

Making Targeted Therapy Compatible with Checkpoint Immunotherapy.

Fernández A.

Trends Biotechnol. 2017 Jul;35(7):582-584. doi: 10.1016/j.tibtech.2017.02.008. Epub 2017 Mar 8.

PMID:
28283197
10.

Advanced Modeling Reconciles Counterintuitive Decisions in Lead Optimization.

Fernández A, Scott LR.

Trends Biotechnol. 2017 Jun;35(6):490-497. doi: 10.1016/j.tibtech.2016.12.003. Epub 2017 Jan 7. Review.

PMID:
28069262
11.

Non-Debye frustrated hydration steers biomolecular association: interfacial tension for the drug designer.

Fernández A.

FEBS Lett. 2016 Oct;590(20):3481-3491. doi: 10.1002/1873-3468.12418. Epub 2016 Oct 2.

12.

Risk factors for advanced resuscitation in term and near-term infants: a case-control study.

Berazategui JP, Aguilar A, Escobedo M, Dannaway D, Guinsburg R, de Almeida MF, Saker F, Fernández A, Albornoz G, Valera M, Amado D, Puig G, Althabe F, Szyld E; ANR study group.

Arch Dis Child Fetal Neonatal Ed. 2017 Jan;102(1):F44-F50. doi: 10.1136/archdischild-2015-309525. Epub 2016 Jun 6.

PMID:
27269195
13.

Reconstruction of perspective shifts and refocusing of a three-dimensional scene from a multi-focus image stack.

Alonso JR, Fernández A, Ferrari JA.

Appl Opt. 2016 Mar 20;55(9):2380-6. doi: 10.1364/AO.55.002380.

PMID:
27140577
14.

Image segmentation by nonlinear filtering of optical Hough transform.

Fernández A, Flores JL, Alonso JR, Ferrari JA.

Appl Opt. 2016 May 1;55(13):3632-8. doi: 10.1364/AO.55.003632.

PMID:
27140381
15.

Real-time pattern recognition using an optical generalized Hough transform.

Fernández A, Flores JL, Alonso JR, Ferrari JA.

Appl Opt. 2015 Dec 20;54(36):10586-91. doi: 10.1364/AO.54.010586.

PMID:
26837021
16.

Acid-base chemistry of frustrated water at protein interfaces.

Fernández A.

FEBS Lett. 2016 Jan;590(2):215-23. doi: 10.1002/1873-3468.12047. Epub 2016 Jan 5.

17.

Effectiveness of an mHealth intervention to improve the cardiometabolic profile of people with prehypertension in low-resource urban settings in Latin America: a randomised controlled trial.

Rubinstein A, Miranda JJ, Beratarrechea A, Diez-Canseco F, Kanter R, Gutierrez L, Bernabé-Ortiz A, Irazola V, Fernandez A, Letona P, Martínez H, Ramirez-Zea M; GISMAL group.

Lancet Diabetes Endocrinol. 2016 Jan;4(1):52-63. doi: 10.1016/S2213-8587(15)00381-2. Epub 2015 Dec 1.

PMID:
26653067
18.

Drug leads for interactive protein targets with unknown structure.

Fernández A, Scott LR.

Drug Discov Today. 2016 Apr;21(4):531-5. doi: 10.1016/j.drudis.2015.10.006. Epub 2015 Oct 17.

PMID:
26484433
19.

[Acceptability of a mobile health based intervention to modify lifestyles in prehypertensive patients in Argentina, Guatemala and Peru: a pilot study].

Beratarrechea A, Diez-Canseco F, Fernández A, Kanter R, Letona P, Martinez H, Miranda JJ, Ramirez-Zea M, Rubinstein A.

Rev Peru Med Exp Salud Publica. 2015 Apr-Jun;32(2):221-9. Spanish.

20.

Pediatric Index of Mortality 2 as a predictor of death risk in children admitted to pediatric intensive care units in Latin America: A prospective, multicenter study.

Arias Lopez MP, Fernández AL, Ratto ME, Saligari L, Serrate AS, Ko IJ, Troster E, Schnitzler E; ValidarPIM2 Latin American Group.

J Crit Care. 2015 Dec;30(6):1324-30. doi: 10.1016/j.jcrc.2015.08.001. Epub 2015 Aug 5.

PMID:
26337557

Supplemental Content

Loading ...
Support Center